Site Sponsors
  • Strem Chemicals - Nanomaterials for R&D
  • Oxford Instruments Nanoanalysis - X-Max Large Area Analytical EDS SDD
  • Park Systems - Manufacturer of a complete range of AFM solutions
Posted in | Nanomedicine | Nanobusiness

Global Industry Analysis Report on Nanomedicine Market

Published on February 20, 2014 at 5:46 AM

Research and Markets has announced the addition of the "Nanomedicine Market - Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 - 2019" report to their offering.

This report includes market estimations for the nanomedicine market for the forecast period 2013 - 2019. The market size is represented in terms of USD billion and the market estimates and forecasts are calculated, considering 2012 as the base year. Moreover, market trends and recent developments have been kept into account while forecasting market growth and revenue for the period 2013 - 2019.

The overall nanomedicine market is segmented on the basis of application and geography and the market estimations for each of these segments, in terms of USD billion, is provided in this report.

The nanomedicine market, by applications is segmented into neurological, cardiovascular, oncology, anti-inflammatory, anti-infective and other markets. The nanomedicine market is also estimated and analyzed on the basis of geographic regions such as North America, Europe, Asia-Pacific and rest of the world.

The global trends such as drivers, restraints and opportunities of the global nanomedicine market is detailed in the market overview chapter of this report., with a view on impact of these factors on market growth along the course of the forecast period.

The chapter on competitive landscape consists of heat map analysis of the key players operating in the global nanomedicine market. Some of the key players of this market include GE Healthcare, Mallinckrodt plc, Nanosphere Inc., Pfizer Inc., Merck & Co Inc., Celgene Corporation, CombiMatrix Corporation, Abbott Laboratories and others. The role of these market players in the global nanomedicine market is analyzed by profiling them on the basis of attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments.

The global nanomedicine market is categorized into the following segments:

  • Neurology
  • Cardiovascular
  • Anti-Inflammatory
  • Anti-Infectives
  • Oncology
  • Others

Key Topics Covered:

Chapter 1 Preface

Chapter 2 Executive Summary

Chapter 3 Global Nanomedicine Market Overview

Chapter 4 Global Nanomedicine Market, by Applications

Chapter 5 Global Nanomedicine Market, by Geography

Chapter 6 Recommendations

Chapter 7 Company Profiles

  • Abbott Laboratories
  • Celgene Corporation
  • CombiMatrix Corporation
  • GE Healthcare
  • Johnson & Johnson
  • Mallinckrodt plc.
  • Merck & Company Inc.
  • Nanosphere, Inc.
  • Pfizer Inc.
  • Sigma-Tau Pharmaceuticals Inc.
  • Teva Pharmaceutical Industries Ltd.
  • UCB SA

For more information visit http://www.researchandmarkets.com/research/klznmd/nanomedicine

Source: http://www.researchandmarkets.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Submit